Paper33526596
Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
Naydenova K and 14 others. Proc Natl Acad Sci U S A, 2021. Cited by 146 papers, by iCite.
Cite this record
ConductScience Library. Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP. Papers, record 33526596. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33526596
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amides | Major topic |
| Coronavirus RNA-Dependent RNA Polymerase | Major topic |
| Enzyme Inhibitors | Major topic |
| Pyrazines | Major topic |
| SARS-CoV-2 | Major topic |
| Cryoelectron Microscopy | |
| Ribonucleotides | |
| Single Molecule Imaging |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 24307 | Cancer Research UK | United Kingdom | PubMed | |
| MC_UP_1201/17 | Medical Research Council | United Kingdom | PubMed | |
| MC_UP_1201/6 | Medical Research Council | United Kingdom | PubMed | |
| Wellcome Trust | United Kingdom | PubMed | ||
| MC_U105184326 | Medical Research Council | United Kingdom | PubMed | |
| 2027541Z/16/Z | Wellcome Trust | United Kingdom | PubMed | |
| 14109 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27910462 | A precision cryostat design for manual and semi-automated cryo-plunge instruments. | Rev Sci Instrum | 2016 | https://conductscience.org/library/papers/27910462 | PubMed |
| 2 | 31127045 | Multifunctional graphene supports for electron cryomicroscopy. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31127045 | PubMed |
| 3 | 32438371 | Structure of replicating SARS-CoV-2 polymerase. | Nature | 2020 | https://conductscience.org/library/papers/32438371 | PubMed |
| 4 | 30713699 | A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. | IUCrJ | 2019 | https://conductscience.org/library/papers/30713699 | PubMed |
| 5 | 23917318 | Mechanism of action of T-705 ribosyl triphosphate against influenza virus RNA polymerase. | Antimicrob Agents Chemother | 2013 | https://conductscience.org/library/papers/23917318 | PubMed |
| 6 | 31138817 | Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. | Nat Commun | 2019 | https://conductscience.org/library/papers/31138817 | PubMed |
| 7 | 30352857 | The mechanism of resistance to favipiravir in influenza. | Proc Natl Acad Sci U S A | 2018 | https://conductscience.org/library/papers/30352857 | PubMed |
| 8 | 26454197 | Recombinant expression and reconstitution of multiprotein complexes by the USER cloning method in the insect cell-baculovirus expression system. | Methods | 2016 | https://conductscience.org/library/papers/26454197 | PubMed |
| 9 | 31588918 | Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. | Acta Crystallogr D Struct Biol | 2019 | https://conductscience.org/library/papers/31588918 | PubMed |
| 10 | 33037151 | Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity. | Proc Natl Acad Sci U S A | 2020 | https://conductscience.org/library/papers/33037151 | PubMed |
| 11 | 33521757 | Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir. | Innovation (Camb) | 2021 | https://conductscience.org/library/papers/33521757 | PubMed |
| 12 | 32526208 | Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase. | Cell | 2020 | https://conductscience.org/library/papers/32526208 | PubMed |
| 13 | 33264556 | Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33264556 | PubMed |
| 14 | 32943628 | Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis. | Nat Commun | 2020 | https://conductscience.org/library/papers/32943628 | PubMed |
| 15 | 35740211 | Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35740211 | PubMed |
| 16 | 32304664 | A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase. | Cell | 2020 | https://conductscience.org/library/papers/32304664 | PubMed |
| 17 | 32370758 | SARS-CoV-2 RNA polymerase as target for antiviral therapy. | J Transl Med | 2020 | https://conductscience.org/library/papers/32370758 | PubMed |
| 18 | 3193246 | Controlled environment vitrification system: an improved sample preparation technique. | J Electron Microsc Tech | 1988 | https://conductscience.org/library/papers/3193246 | PubMed |
| 19 | 20383002 | Features and development of Coot. | Acta Crystallogr D Biol Crystallogr | 2010 | https://conductscience.org/library/papers/20383002 | PubMed |
| 20 | 25333492 | Favipiravir elicits antiviral mutagenesis during virus replication in vivo. | Elife | 2014 | https://conductscience.org/library/papers/25333492 | PubMed |
Cited by102
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 146 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794799 | HPLC-HRMS/MS Characterization, Molecular Docking, and Comparative Genotoxicity of Free and Liposome-Encapsulated Aesculus hippocastanum Seed Extract. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794799 | PubMed |
| 42655636 | Human Coronavirus Photodynamic Inactivation and In Silico Mechanisms Induced by Ga(III) vs. Zn(II) Phthalocyanines. | Viruses | 2026 | https://conductscience.org/library/papers/42655636 | PubMed |
| 41465446 | Designing Novel Compound Candidates Against SARS-CoV-2 Using Generative Deep Neural Networks and Cheminformatics. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465446 | PubMed |
| 40741617 | Multitarget-based in silico screening from phytoactive compounds of Garcinia linii fighting toward severe acute respiratory syndrome coronavirus-2. | Tzu Chi Med J | 2025 | https://conductscience.org/library/papers/40741617 | PubMed |
| 39995122 | Unfurling the Potential of Antiviral Agents Aimed for RNA Virus Ailment. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/39995122 | PubMed |
| 39860219 | Research Progress on the Structure and Function, Immune Escape Mechanism, Antiviral Drug Development Methods, and Clinical Use of SARS-CoV-2 Mpro. | Molecules | 2025 | https://conductscience.org/library/papers/39860219 | PubMed |
| 39628968 | Theoretical biological activities and docking studies of new derivatives of acyclovir for the treatment of coronavirus disease 2019. | J Med Life | 2024 | https://conductscience.org/library/papers/39628968 | PubMed |
| 39625895 | Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assays. | PLoS One | 2024 | https://conductscience.org/library/papers/39625895 | PubMed |
| 39559548 | SARS-CoV-2 Resistance to Small Molecule Inhibitors. | Curr Clin Microbiol Rep | 2024 | https://conductscience.org/library/papers/39559548 | PubMed |
| 39348391 | N4-Hydroxycytidine/molnupiravir inhibits RNA virus-induced encephalitis by producing less fit mutated viruses. | PLoS Pathog | 2024 | https://conductscience.org/library/papers/39348391 | PubMed |
| 39269493 | Hydroxyl radical-induced C1'-H abstraction reaction of different artificial nucleotides. | J Mol Model | 2024 | https://conductscience.org/library/papers/39269493 | PubMed |
| 38821943 | Nanoscale cellular organization of viral RNA and proteins in SARS-CoV-2 replication organelles. | Nat Commun | 2024 | https://conductscience.org/library/papers/38821943 | PubMed |
| 38257352 | Favipiravir Analogues as Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase, Combined Quantum Chemical Modeling, Quantitative Structure-Property Relationship, and Molecular Docking Study. | Molecules | 2024 | https://conductscience.org/library/papers/38257352 | PubMed |
| 38008055 | Accurate magnification determination for cryoEM using gold. | Ultramicroscopy | 2024 | https://conductscience.org/library/papers/38008055 | PubMed |
| 38005857 | Covalent Inhibitors from Saudi Medicinal Plants Target RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2. | Viruses | 2023 | https://conductscience.org/library/papers/38005857 | PubMed |
| 37986994 | Nanoscale cellular organization of viral RNA and proteins in SARS-CoV-2 replication organelles. | bioRxiv | 2024 | https://conductscience.org/library/papers/37986994 | PubMed |
| 37790934 | What do we know about the function of SARS-CoV-2 proteins? | Front Immunol | 2023 | https://conductscience.org/library/papers/37790934 | PubMed |
| 37783885 | CryoREAD: de novo structure modeling for nucleic acids in cryo-EM maps using deep learning. | Nat Methods | 2023 | https://conductscience.org/library/papers/37783885 | PubMed |
| 37711189 | Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/37711189 | PubMed |
| 37665006 | SARS-CoV-2 Nsp8 N-terminal domain folds autonomously and binds dsRNA. | Nucleic Acids Res | 2023 | https://conductscience.org/library/papers/37665006 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AOPEP | 84909 | PubTator's text mining | https://conductscience.org/library/genes/84909 | NCBI Gene |
| HFM1 | 164045 | PubTator's text mining | https://conductscience.org/library/genes/164045 | NCBI Gene |
| MORN4 | 118812 | PubTator's text mining | https://conductscience.org/library/genes/118812 | NCBI Gene |
| NDRG1 | 10397 | PubTator's text mining | https://conductscience.org/library/genes/10397 | NCBI Gene |
| SPECC1 | 92521 | PubTator's text mining | https://conductscience.org/library/genes/92521 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33526596
GET https://conductscience.org/api/papers/v1/33526596/references?page=2